AETERNA ZENTARIS INC (AEZS) Fundamental Analysis & Valuation

NASDAQ:AEZS • CA0079756007

Current stock price

5.72 USD
+0.32 (+5.93%)
Last:

This AEZS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AEZS Profitability Analysis

1.1 Basic Checks

  • In the past year AEZS has reported negative net income.
  • In the past year AEZS has reported a negative cash flow from operations.
  • In the past 5 years AEZS always reported negative net income.
  • AEZS had a negative operating cash flow in each of the past 5 years.
AEZS Yearly Net Income VS EBIT VS OCF VS FCFAEZS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

  • AEZS has a Return On Assets (-56.80%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of -139.22%, AEZS is doing worse than 62.76% of the companies in the same industry.
Industry RankSector Rank
ROA -56.8%
ROE -139.22%
ROIC N/A
ROA(3y)-31.91%
ROA(5y)-27.9%
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AEZS Yearly ROA, ROE, ROICAEZS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400

1.3 Margins

  • AEZS has a better Gross Margin (90.69%) than 93.18% of its industry peers.
  • In the last couple of years the Gross Margin of AEZS has remained more or less at the same level.
  • AEZS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.35%
GM growth 5Y0.62%
AEZS Yearly Profit, Operating, Gross MarginsAEZS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AEZS Health Analysis

2.1 Basic Checks

  • AEZS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AEZS has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, AEZS has a worse debt to assets ratio.
AEZS Yearly Shares OutstandingAEZS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
AEZS Yearly Total Debt VS Total AssetsAEZS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

  • AEZS has an Altman-Z score of -16.76. This is a bad value and indicates that AEZS is not financially healthy and even has some risk of bankruptcy.
  • AEZS has a Altman-Z score of -16.76. This is amonst the worse of the industry: AEZS underperforms 85.49% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that AEZS is not too dependend on debt financing.
  • AEZS has a Debt to Equity ratio (0.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -16.76
ROIC/WACCN/A
WACC10.12%
AEZS Yearly LT Debt VS Equity VS FCFAEZS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

  • AEZS has a Current Ratio of 5.94. This indicates that AEZS is financially healthy and has no problem in meeting its short term obligations.
  • AEZS has a Current ratio of 5.94. This is comparable to the rest of the industry: AEZS outperforms 59.09% of its industry peers.
  • AEZS has a Quick Ratio of 5.93. This indicates that AEZS is financially healthy and has no problem in meeting its short term obligations.
  • AEZS has a Quick ratio (5.93) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 5.94
Quick Ratio 5.93
AEZS Yearly Current Assets VS Current LiabilitesAEZS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. AEZS Growth Analysis

3.1 Past

  • AEZS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -274.15%.
  • Looking at the last year, AEZS shows a very negative growth in Revenue. The Revenue has decreased by -62.06% in the last year.
  • Measured over the past years, AEZS shows a very negative growth in Revenue. The Revenue has been decreasing by -30.07% on average per year.
EPS 1Y (TTM)-274.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-438.43%
Revenue 1Y (TTM)-62.06%
Revenue growth 3Y6.73%
Revenue growth 5Y-30.07%
Sales Q2Q%-99.81%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y68.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.27%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AEZS Yearly Revenue VS EstimatesAEZS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AEZS Yearly EPS VS EstimatesAEZS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

0

4. AEZS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AEZS. In the last year negative earnings were reported.
  • Also next year AEZS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AEZS Price Earnings VS Forward Price EarningsAEZS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEZS Per share dataAEZS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AEZS Dividend Analysis

5.1 Amount

  • AEZS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AEZS Fundamentals: All Metrics, Ratios and Statistics

AETERNA ZENTARIS INC

NASDAQ:AEZS (8/8/2024, 8:00:00 PM)

5.72

+0.32 (+5.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-08
Earnings (Next)11-07
Inst Owners0.81%
Inst Owner Change11.72%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.51M
Revenue(TTM)2.38M
Net Income(TTM)-18.06M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.37
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)-11
EYN/A
EPS(NY)-3.44
Fwd EYN/A
FCF(TTM)-5.67
FCFYN/A
OCF(TTM)-5.67
OCFYN/A
SpS0.78
BVpS4.24
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -56.8%
ROE -139.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.69%
FCFM N/A
ROA(3y)-31.91%
ROA(5y)-27.9%
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.35%
GM growth 5Y0.62%
F-Score1
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.87%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.94
Quick Ratio 5.93
Altman-Z -16.76
F-Score1
WACC10.12%
ROIC/WACCN/A
Cap/Depr(3y)148.35%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.23%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-274.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-438.43%
EPS Next Y68.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.06%
Revenue growth 3Y6.73%
Revenue growth 5Y-30.07%
Sales Q2Q%-99.81%
Revenue Next Year-2.27%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.97%
OCF growth 3YN/A
OCF growth 5YN/A

AETERNA ZENTARIS INC / AEZS Fundamental Analysis FAQ

What is the fundamental rating for AEZS stock?

ChartMill assigns a fundamental rating of 1 / 10 to AEZS.


Can you provide the valuation status for AETERNA ZENTARIS INC?

ChartMill assigns a valuation rating of 0 / 10 to AETERNA ZENTARIS INC (AEZS). This can be considered as Overvalued.


What is the profitability of AEZS stock?

AETERNA ZENTARIS INC (AEZS) has a profitability rating of 1 / 10.


What is the financial health of AETERNA ZENTARIS INC (AEZS) stock?

The financial health rating of AETERNA ZENTARIS INC (AEZS) is 3 / 10.